$80.0M
sold in all offerings
Cue Biopharma, Inc. is a corporation based in Boston, MA in the Biotechnology industry group. From May 14, 2026 to July 22, 2026 it filed 2 private fundraising filings for 2 offerings and reported $80 million sold in all. It is a listed company (CUE).
Updated October 10, 2026 · newest filing Jul 22, 2026
Amount sold
$80.0M
All offerings, newest filing of each
Offered
$80.0M
Total amount sought
Offerings
2
2 filings with amendments
Newest offering
$50.0M
Sold, first filed Jul 22, 2026
Investors
4
In the newest offering
Min. investment
-
In the newest offering
Facts
- Type
- Corporation
- Place
- Boston, MA
- Industry group
- Biotechnology
- Listed
- CUE
- First filing
- May 14, 2026
- Newest filing
- July 22, 2026
- Exemptions
- 506(b)
Offerings
2 offerings, newest first, each at its newest filing
| First filed | Amount sold | Offered | Investors | Min. investment | Exemptions | Securities |
|---|---|---|---|---|---|---|
| Jul 22, 2026 | $50.0M | $50.0M | 4 | - | 506(b) | Equity, Options or warrants, Securities on exercise of options |
| May 14, 2026 | $30.0M | $30.0M | 118 | - | 506(b) | Options or warrants, Securities on exercise of options, Other |
Filing history
2 filings, newest first. An amendment updates an earlier offering.
| Filed | Kind | Amount sold | Offered | Investors |
|---|---|---|---|---|
| Jul 22, 2026 | New offering | $50.0M | $50.0M | 4 |
| May 14, 2026 | New offering | $30.0M | $30.0M | 118 |
Related pages
Questions and answers
How much has Cue Biopharma, Inc. raised in private offerings?
$80 million sold in 2 private offerings reported from May 14, 2026 to Jul 22, 2026, counting each offering once at its newest filing.
When did Cue Biopharma, Inc. last file about a private offering?
July 22, 2026. Its newest offering reported $50 million sold of $50 million offered to 4 investors.
Which exemption does Cue Biopharma, Inc. use?
506(b). Rule 506(b) does not allow public advertising.
Is Cue Biopharma, Inc. a listed company?
Yes, it is listed as CUE.
These are notices that issuers file about their own private offerings, not verified results. Amounts are as stated in the filing. Official public data from private fundraising filings, updated daily. Amount sold is what the issuer had sold when it filed; the offered amount is the total it wants to raise.